Content area

|
|

Fatalt forløb efter intoksikation med det nye designerdrug 25C-NBOMe

Forfatter(e)
Maren Tarpgaard1, Rikke Mærkedahl1 & Karen Buch Lauridsen2 1) Anæstesi, Regionshospitalet Herning 2) Klinisk Immunologisk Afdeling, Aarhus Universitetshospital Ugeskr Læger 2015;177:V09140523
Reference: 
Ugeskr Læger 2015;177:V09140523
Blad nummer: 
Sidetal: 
2-3
Fatal intoxication with the new designer drug 25C-NBOMe
This is a case report of a 22-year-old man, who snorted the content of three capsules of the new designer drug 25C-NBOMe (2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine). 1-2 hours after the intake he became unconscious with generalized seizures, so he was intubated prehospitally and brought to the local hospital. At admission he had acute renal failure and was severely metabolic acidotic with potassium 8.6 mmol/l, lactate 28 mmol/l and pH 6.69. Despite maximal therapy he died ten hours after admission. 25C-NBOMe is currently legal in most parts of the world, and fatal intoxication with the drug has not yet been described in Scandinavia.
Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Hanne Pedersen | 17/11
1 Kommentar
af Mads Aage Toft Kristensen | 16/11
1 Kommentar
af Ketil Bjerregård | 15/11
1 Kommentar
af Jens Lund Ahrenkiel | 15/11
1 Kommentar
af Nicolaj Markus Stilling | 15/11
2 kommentarer
af Marianne Puge Nielsen | 13/11
1 Kommentar
af Akil Raad Kami Abdel-Wahab Walli | 13/11
6 kommentarer
af Larry Højgaard Kristiansen | 11/11
1 Kommentar